Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$546K Sell
10,824
-616
-5% -$30.3K 0.02% 439
2019
Q2
$549K Sell
11,440
-1,452
-11% -$67.1K 0.02% 435
2019
Q1
$624K Buy
12,892
+880
+7% +$39.7K 0.02% 397
2018
Q4
$494K Sell
12,012
-3,894
-24% -$160K 0.02% 411
2018
Q3
$652K Sell
15,906
-1,518
-9% -$61.4K 0.02% 395
2018
Q2
$693K Buy
17,424
+2,772
+19% +$107K 0.02% 352
2018
Q1
$547K Buy
14,652
+2,420
+20% +$97.8K 0.02% 382
2017
Q4
$523K Buy
12,232
+1,034
+9% +$41.2K 0.02% 419
2017
Q3
$411K Buy
11,198
+1,782
+19% +$71.9K 0.02% 436
2017
Q2
$427K Sell
9,416
-352
-4% -$15.5K 0.02% 411
2017
Q1
$416K Buy
9,768
+880
+10% +$35.9K 0.02% 387
2016
Q4
$356K Buy
+8,888
New +$343K 0.02% 378

Other funds holding HOLX

Neuburgh Advisers's HOLX Position: Q3 2019 in Review

Neuburgh Advisers reduced its Hologic (HOLX) stake by 5.4% in Q3 2019, selling an estimated $30.3K and leaving 10,824 shares worth $546K. The position accounts for 0.02% of the portfolio, ranked #439.

Neuburgh Advisers first reported a position in HOLX in Q4 2016 and has held it in 12 quarters since. The position peaked at $693K in Q2 2018. 493 funds tracked by Wall St. Rank hold HOLX as of Q3 2019.

  • Neuburgh Advisers held 10,824 shares of Hologic worth $546K as of Q3 2019.
  • Neuburgh Advisers sold 616 Hologic shares in Q3 2019, an estimated $30.3K.
  • Hologic made up 0.02% of Neuburgh Advisers's portfolio in Q3 2019, its #439 holding.
  • Neuburgh Advisers first reported a position in Hologic in Q4 2016 and has held it in 12 quarters since.
  • Neuburgh Advisers's Hologic position peaked at $693K in Q2 2018.
  • 493 funds tracked by Wall St. Rank held Hologic as of Q3 2019.

Based on Neuburgh Advisers's 13F filing for Q3 2019, filed 14 Nov 2019.